Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

NCT02118610 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: L-tetrahydropalmatine (30mg)
DRUG: Sugar pill

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]